Research Article
Prognostic Value of Metastatic Tumoral Caveolin-1 Expression in Patients with Resected Gastric Cancer
Table 2
Correlations between clinicopathologic findings and caveolin-1 expression.
| | Primary tumoral Cav-1 expression | Stromal Cav-1 expression | Metastatic tumoral Cav-1 expression | | Low, n (%) | High, n (%) | Low, n (%) | High, n (%) | Low, n (%) | High, n (%) |
| | No. of patients | 127 (87.6) | 18 (12.4) | 109 (77.3) | 32 (22.7) | 76 (83.5) | 15 (16.5) | | TNM stage | | | | | | | | I | 16 (12.6) | 4 (22.2) | 16 (14.7) | 4 (12.5) | 1 (1.3) | 0 (0) | | II | 38 (29.9) | 6 (33.3) | 33 (30.3) | 9 (28.1) | 10 (13.2) | 3 (20.0) | | III | 73 (57.5) | 8 (44.5) | 60 (55.0) | 19 (59.4) | 65 (85.5) | 12 (80.0) | | value | | 0.431 | | 0.960 | | 0.540 | | Tumor grade | | | | | | | | Well | 15 (11.8) | 1 (5.6) | 9 (8.3) | 6 (18.8) | 3 (3.9) | 1 (6.7) | | Moderately–poorly | 112 (88.2) | 17 (94.4) | 100 (91.7) | 26 (81.2) | 73 (96.1) | 14 (93.3) | | value | | 0.694 | | 0.106 | | 0.520 | | Lymphatic invasion | | | | | | | | No | 22 (17.5) | 5 (27.8) | 21 (19.4) | 6 (18.8) | 4 (5.3) | 0 (0) | | Yes | 104 (82.5) | 13 (72.2) | 87 (80.6) | 26 (81.2) | 72 (94.7) | 15 (100) | | value | | 0.333 | | 1 | | 1 | | Vascular invasion | | | | | | | | No | 110 (90.9) | 17 (94.4) | 95 (92.2) | 28 (87.5) | 67 (90.3) | 10 (71.4) | | Yes | 11 (9.1) | 1 (5.6) | 8 (7.8) | 4 (12.5) | 7 (9.70) | 4 (28.6) | | value | | 1 | | 0.478 | | 0.069 | | Lauren classification | | | | | | | | Nondiffuse type | 60 (47.2) | 8 (44.4) | 46 (41.8) | 20 (62.5) | 29 (37.8) | 9 (60.0) | | Diffuse type | 67 (52.8) | 10 (55.6) | 63 (58.2) | 12 (37.5) | 47 (62.2) | 6 (40.0) | | value | | 1 | | 0.045 | | 0.154 |
|
|
Statistically significant ().
|
